CNS response after erlotinib therapy in a patient with metastatic NSCLC with an EGFR mutation
Erlotinib for frontline treatment of advanced non-small cell lung cancer: a phase II study.
Endothelial Protein C Receptor Gene Variants Not Associated with Severe Malaria in Ghanaian Children